Search - tctmd.com

Displaying 21 - 40 of 73

Sort: Relevancy | Date

News Daily News

BASIL-2 Supports Endo-First Strategy for CLTI With Infrapopliteal Disease

L.A. McKeown

May 01, 2023

News Daily News

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

L.A. McKeown

March 29, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2022

Caitlin E. Cox

December 01, 2022

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

Presentation ESC 2022

International Study Of Comparative Health Effectiveness With Medical And Invasive Approaches - Chronic Kidney Disease EXTENDed Follow-up: Survival at 5 years of Follow-up

Presenter: Sripal Bangalore

August 29, 2022

News Conference News SCAI 2022

Cocaine History? For Black Patients It Means Less Chance of Revascularization

L.A. McKeown

May 26, 2022

News Daily News

Worse Survival for Women After Ruptured AAA Repair

L.A. McKeown

May 11, 2022

News Daily News

PAD Significantly Ups Morbidity and Mortality in AMICS

L.A. McKeown

March 29, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Opinion CV Team Dispatch

September 2021 News Roundup

L.A. McKeown

September 01, 2021

News Opinion Editor's Corner ESC 2021

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Shelley Wood

August 19, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Conference News ACC 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Michael O'Riordan

May 16, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2020

Shelley Wood

November 30, 2020

News Conference News AHA 2020

One in Five Patients Admitted With COVID-19 Die in the Hospital

Michael O'Riordan

November 20, 2020

News Daily News

Outcome Differences Between Men and Women With PAD: EUCLID Insights

L.A. McKeown

February 11, 2020

CIN Prevention II: Clinical Trials Summary of Completed and Ongoing Studies

Presentation TCT 2019

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Presenter: Somjot Brar

September 28, 2019

Advertisement

BASIL-2 Supports Endo-First Strategy for CLTI With Infrapopliteal Disease

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

Only Half of Revascularized PAD Patients Receive GDMT

TCTMD’s Top 10 Most Popular Stories for November 2022

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

September 2022 News Roundup

International Study Of Comparative Health Effectiveness With Medical And Invasive Approaches - Chronic Kidney Disease EXTENDed Follow-up: Survival at 5 years of Follow-up

Cocaine History? For Black Patients It Means Less Chance of Revascularization

Worse Survival for Women After Ruptured AAA Repair

PAD Significantly Ups Morbidity and Mortality in AMICS

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

September 2021 News Roundup

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

TCTMD’s Top 10 Most Popular Stories for November 2020

One in Five Patients Admitted With COVID-19 Die in the Hospital

Outcome Differences Between Men and Women With PAD: EUCLID Insights

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content